ScanGeni Ventures · Bengaluru · Est. 2024 · Ingest · Analyze · Decide · Execute
You are not behind. But the window is narrowing. The companies that will define the next decade are being built right now — on assumptions your competitors haven't questioned yet. We have spent 25 years helping organisations navigate exactly this kind of moment. And we have already crossed to the other side of this one. We built seven businesses to prove it.
See what just became possibleDelivered in 2 hours. Not 3 weeks. Same institutional methodology.
World's only per-ingredient allergen database at this scale. Built by agents.
Running simultaneously on an agent matrix. No team. Live today.
The experience that makes the new model trustworthy — not just exciting.
Every industry is being rebuilt by people asking one question: "If we were starting this today — would we build it like this?" Almost every industry is answering no. The rebuilding has begun. The question is whether you are ahead of it or behind it.
Before: Product-level allergen tags. Incomplete. Often wrong.
Every other database tells you a product contains nuts. Ours tells you which ingredient, in which amount, with which cross-contamination risk — across 5 million products, sourced directly from manufacturer-stated label data, AI-analysed. The infrastructure three consumer apps run on. Now available to yours via the NutriGraph API.
5M+ Products. Per ingredient. Sub-50ms.Before: 50,000. Three weeks. An MBB engagement you may not be able to afford.
Your own financials reveal the strategic decisions hiding in plain sight. The market's lens reveals what your board doesn't yet know it's being judged on. Copeland Research brings both into the same room — and tells you what to do about it. Built on 25 years of institutional methodology. Full auditable Excel model. Free trial available today.
<2h Delivery. Vs 3 weeks at 50K from MBB.Before: Running one business well required a team. Running seven required a conglomerate.
Not a case study. Not a pilot programme. A live, auditable holding company — consumer apps, enterprise APIs, strategic intelligence platforms — operated by twelve specialised AI agents running every function simultaneously. This is ScanGeni Ventures today. And through Agentique, it is a model available to your organisation.
7 Live businesses. One operator. Zero traditional overhead.Each venture started with one question to one industry. Here is what changed — and why it matters to the people it serves.
You will never stand in a supermarket aisle guessing again.
Scan any barcode. Know every allergen, every dietary flag, every ingredient — against your personal profile, in seconds. Built for the 1-in-3 people who deserve to eat without anxiety.
World's only per-ingredient allergen databaseKnow exactly what's in your pet's bowl — before it causes harm.
The pet food industry relies on you not reading the label closely enough. Clinical AI, breed-specific allergen profiles, and live FDA recall monitoring — so you don't have to take their word for it.
Finally know what your skincare is really doing to your skin.
INCI labels were designed by chemists, not consumers. Personalised ingredient intelligence — irritant flags, hidden allergens, skin-type analysis — so what goes on your face is genuinely your choice.
Your app gets the food intelligence layer it would take years to build — available today, sub-50ms.
Every product. Every attribute. The world's only food database with per-ingredient allergen tagging at scale — 5M+ products, AI-analysed, sourced from manufacturer-stated label data. Two intelligence layers, 30+ clean label fields, 6 quality scores.
Know about the regulation change before your legal team does.
FDA and USDA pipeline monitoring, allergen regulation updates, and food safety compliance requirements — interpreted and surfaced in real time. For food businesses, legal teams, and compliance professionals who cannot afford to be the last to know.
The analysis your board has been asking for. In 2 hours. Not 3 weeks.
Your own financials reveal the strategic decisions hiding in plain sight. The market's lens reveals what your board doesn't yet know it's being judged on. Copeland Research brings both into the same room — and tells you what to do about it. Built on 25 years of institutional methodology.
Publish across 10+ platforms with AI-powered optimization. Scale reach without scaling headcount.
AI-powered growth automation — the external-facing version of the V4 Intent Engine that runs ScanGeni's own content operations. Automate content publishing, optimize for platform-specific performance, and grow your audience systematically. Built from the inside out: we use it ourselves.
You don't need to become a technologist. You need to understand the business decision in front of you. These are the seven things we'd put in front of any CEO navigating this moment — curated for the boardroom, not the engineering team. Plus three pieces of thinking from inside ScanGeni Ventures, coming soon.
From the people shaping this — curated for business leaders
McKinsey · October 2025
The Change Agent: Goals, Decisions and Implications for CEOs in the Agentic Age
Written directly for CEOs — not technologists. A two-year roadmap for navigating this transition. If you read one thing on this list, read this. McKinsey studied over 50 real agentic builds to write it.
Article · 15 min readMcKinsey · November 2025
Agentic AI Explained: When Machines Don't Just Chat — But Act
McKinsey's clearest explanation of what agentic AI actually is — how it's different from the chatbot you've already used, and where the real business opportunity lies amid the hype. Video series format. Accessible in 20 minutes.
Video · 20 minMcKinsey · September 2025
The Agentic Organisation: Contours of the Next Paradigm for the AI Era
The most comprehensive business case for why this is a structural shift — not a productivity tool. McKinsey's framework for how organisations will be redesigned around agent networks. This is the strategic context your board will eventually be asking you about.
Article · 20 min readTED · Sam Altman · April 2025
ChatGPT, AI Agents and Superintelligence — Live at TED 2025
The clearest 20-minute explanation of where this is going — from the person building it. Not technical. Boardroom-ready language. Sam Altman answers the questions every CEO has been quietly asking. If your board wants context, this is the video to share.
Video · 20 minY Combinator · Garry Tan · April 2025
The Next Breakthrough in AI Agents Is Here
Y Combinator — the organisation that backed Airbnb, Stripe, and Dropbox — is now saying agents that can genuinely act on business tasks have arrived. If YC is saying it, the market has already moved. This is Garry Tan explaining why and what it means for company building.
Video · 15 minAndrej Karpathy · YouTube
Intro to Large Language Models
Karpathy is the ex-OpenAI founding scientist who explains hard things in plain language. This 1-hour video is the best non-technical introduction to what LLMs actually are — not the hype, the mechanics. You don't need to watch all of it. The first 20 minutes will change how you think about every AI conversation you've had.
Video · 1 hourScanGeni Ventures · Live
Stop reading about it. Here is a live agentic company.
Seven businesses. Twelve agents. One operator. Running right now. The HQ dashboard shows the operating model in real time — agent activity, venture telemetry, the whole system live. This is what the McKinsey articles are describing. You can look at it today.
Live DashboardFrom ScanGeni Ventures — thinking from the inside
Essay · Coming soon
Not "what AI tools should we adopt?" The question that changes the conversation entirely — and why most boards are asking the wrong one.
Publishing shortly
Analysis · Coming soon
We have built seven businesses on agents. We have seen what works and what stalls. The difference is not budget, or technology, or talent. It is one structural decision made at the start.
Publishing shortly
Case Study · Coming soon
The operating model that runs ScanGeni Ventures did not arrive fully formed. Here is what we got wrong, what we changed, and what we would do differently if we were starting today.
Publishing shortly
Twenty-five years advising boards and PE houses through structural change teaches you one thing: the organisations that navigate these moments well are not the ones who move fastest. They are the ones who move with the right guide.
We are not evangelists for AI. We are strategists who have spent 25 years understanding how businesses create value — and who have now built the proof that the new model works. The portfolio is not a claim. It is an auditable, running set of businesses you can examine today.
"We build companies the way they would be built if they were invented today. The result looks nothing like what came before."
sessions_spawn, consolidates via sessions_yield. Never executes specialist tasks — pure orchestration.Every industry has a constraint that shaped how it was built — and that no longer exists. We identify it. We ask the question your competitors haven't asked yet. That is always the starting point.
Not an improvement on what came before. The replacement — built with the right data layer, the right intelligence, and the right operating model. Grounded in 25 years of understanding where value actually comes from.
Every venture we build runs on an agent matrix from day one. We then offer the same capability to you — not as a concept, but as a running system you can see, question, and adapt for your own organisation.
This is not a revolution you need to leap into. It is a bridge you cross step by step, with someone who has already been to the other side. That is what Agentique is. That is what ScanGeni Ventures is.
For CEOs & Leadership Teams
If you are trying to understand what AI genuinely means for your business — not the hype, not the headlines, but the specific decisions you need to make — this is the conversation to have. We bring 25 years of strategic clarity and a live proof-of-concept. You bring the questions you haven't been able to ask anyone yet.
Start the conversation Connect on LinkedInFor Investors & Partners
Seven ventures. Four categories. Three breakthroughs already live and scaling. The thesis — that agentic companies will structurally outperform traditional ones — is not a prediction. It is already happening. The evidence is auditable today.
Investor enquiriesFounded and led by a strategy consultant with 25 years advising boards, PE houses, and family offices across Asia, the Middle East, and Europe on capital allocation, M&A, and shareholder value creation. The same methodology now runs autonomously inside Copeland Research. The same conviction about structural change built every venture in this portfolio.
Meet the founder →